Protocol summary

Study aim
Evaluation of the effect of transcranial direct current stimulation, olfactory stimulation and their combination in intensive care unit (ICU) patients with disorder of consciousness (DOC)
Design
A controlled, parallel-group, double-blind, randomized, phase 3 clinical trial on 60 patients. A computer randomization sequence was used for randomization.
Settings and conduct
This study is conducted as a clinical trial on the patients of the intensive care unit with disorder of consciousness referred to Loghman Hakim Hospital. Patients who meet the inclusion criteria are randomly assigned to one of three groups. The data will be coded and without the patient's name and grouping, and in sealed envelopes, will be provided to the person analyzing the data.The patient and the person evaluating the data are blind.
Participants/Inclusion and exclusion criteria
Inclusion criteria included age ≥ 18 years, brain injuries, non-hemorrhagic stroke, Glasgow Coma Scale greater than 9, 7. Patients without tracheostomy, and exclusion criteria included complications reducing brain function, referral to other centers, and patient death.
Intervention groups
In the transcranial direct current stimulation (tDCS) group, participants will receive tDCS daily for five consecutive days in 20-minute sessions targeting areas of the brain involved in consciousness, such as the left dorsolateral prefrontal cortex (DLPFC).In the olfactory stimulation group, the participants are subjected to olfactory stimulation for 15 minutes, twice a day, for a period of five days, using unpleasant scents and the stimulant pyridine. In the combination group, participants will receive both tDCS and olfactory stimulation.
Main outcome variables
Glasgow Coma Scale; quantitative electroencephalography; length of stay in ICU; Complications of hospitalization in ICU; Prognosis, tDCS stimulation; olfactory stimulation

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20240608062040N1
Registration date: 2024-06-21, 1403/04/01
Registration timing: prospective

Last update: 2024-06-21, 1403/04/01
Update count: 0
Registration date
2024-06-21, 1403/04/01
Registrant information
Name
Ali Vafaei
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8869 2109
Email address
avafaei.dr@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-07-22, 1403/05/01
Expected recruitment end date
2024-12-21, 1403/10/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluating the effect of transcranial direct current stimulation, olfactory stimulation and their combination in intensive care unit (ICU) patients with disorder of consciousness (DOC)
Public title
The effect of transcranial direct current stimulation and olfactory stimulation in intensive care unit (ICU) patients with disorder of consciousness (DOC)
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age above 18 years People with brain damage Non-hemorrhagic cerebrovascular accident (CVA) Glasgow Coma Scale (GCS) greater than 9 No administration of neuromuscular system blockers or sedatives within 24 hours after entering the study Diagnosis of unresponsive wakefulness syndrome (UWS) or minimally conscious state (MCS), based on repeated behavioral assessments using the Coma Recovery Scale-Revised (CRS-R) (ie, at least five assessments per week) Patients without tracheostomy Patients without intracerebral hemorrhage (ICH) Patients without subarachnoid hemorrhage (SAH) Patients without intubation Patients without previous history of neurological or psychiatric disease Patients who did not use neuromuscular blocking drugs or sedative drugs in the 24 hours before the test. Patients with no documented history of previous coma, critical illness, or unstable medical condition Patients with no history of seizures
Exclusion criteria:
The patient suffers from a complication that reduces brain function
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Participants will be randomly assigned to one of the three intervention groups using a computerized randomization sequence conducted by an independent investigator not involved in the study. Randomization after homogenization of the groups is done based on the confounding variable i.e. age and is classified based on the severity of the disorder according to the basic GCS scores to ensure a balanced distribution of the participants among the intervention groups.
Blinding (investigator's opinion)
Double blinded
Blinding description
Outcome assessments, including clinical assessments and quantitative electroencephalography (QEEG) measurements, will be performed by blind assessors who are unaware of the participants' assigned interventions. Patients have a reduced level of consciousness. There is also a group of patients who receive the sham TDCS protocol and the patients do not know which group they are in. Also, the person doing the electrical stimulation and the person doing the clinical assessment are different people.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee in biomedical research of Shahid Beheshti medical school
Street address
Yemen St, Shahid Chamran Highway
City
Tehran
Province
Tehran
Postal code
1983969411
Approval date
2024-05-21, 1403/03/01
Ethics committee reference number
IR.SBMU.MSP.REC.1403.153

Health conditions studied

1

Description of health condition studied
Disorder of consciousness
ICD-10 code
R41.82
ICD-10 code description
Altered mental status, unspecified

Primary outcomes

1

Description
ICU coma scores
Timepoint
Daily during intervention stages
Method of measurement
Glasgow coma scale

2

Description
Quantitative electroencephalography(QEEG)
Timepoint
At the beginning of the intervention, immediately after the intervention and at the follow-up times (weekly and after 4 weeks of the intervention)
Method of measurement
QEEG brain mapping test

Secondary outcomes

1

Description
Safety monitoring of patients
Timepoint
Every week for four weeks after the intervention
Method of measurement
Side effects and potential side effects related to tDCS and olfactory stimulation will be carefully monitored using the Coma Recovery Scale-revised(CRS-R) during the study.

Intervention groups

1

Description
Intervention group: In the tDCS group, participants received transcranial direct current stimulation in brain regions involved in consciousness, such as the left dorsolateral prefrontal cortex, daily for five consecutive days and 20 minutes.
Category
Treatment - Other

2

Description
Intervention group: In the olfactory stimulation group, participants will receive olfactory stimulation using unpleasant and stimulating odors, pyridine. Participants in this group will receive olfactory stimulation using pyridine for 15 minutes twice a day over the same five-day period.
Category
Treatment - Other

3

Description
Control group: In the combination group, participants will receive both tDCS and olfactory stimulation.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Loghman Hakim Hospital
Full name of responsible person
Ali Vafaei
Street address
Lashgar Crossroads, South Kargar Street
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9009
Email
avafaei.dr@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Afshin Zarghi
Street address
Yemen St, Shahid Chamran Highway
City
Tehran
Province
Tehran
Postal code
1983969411
Phone
+98 21 8820 0096
Email
zarghi@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Ali Vafaei
Position
Sub specialist
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Lashgar Crossroads, South Kargar Street, Loghman Hakim Hospital
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9005
Email
avafaei.dr@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Masood Zangi
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Lashgar Crossroads, South Kargar Street, Loghman Hakim Hospital
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9009
Email
masood_zangi@sbmu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Mahdi Amirdosara
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Lashgar Crossroads, South Kargar Street, Loghman Hakim Hospital
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9009
Email
dr.amirdosara@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...